Product Description
Overall, the global patent ductus arteriosus closure device market was valued at $245.6 million in 2025. This is expected to increase over the forecast period at a CAGR of 5.7% to reach $362 million.
The full report suite on the global market for patent ductus arteriosus (PDA) closure device includes minimally invasive devices used in procedure to close the ductus arteriosus.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Patent Ductus Arteriosus Closure Device Market Trends
The patent ductus arteriosus (PDA) closure device market is constrained by the relatively low prevalence of the defect, particularly beyond infancy. While PDA is more commonly identified in neonates and premature infants, a portion of cases remain small or asymptomatic and may go undetected or untreated into adulthood. This limited and well-defined patient population restricts overall unit volume growth and reduces the incentive for significant new market entry or disruptive innovation.
Patent Ductus Arteriosus Closure Device Market Share Insights
- Abbott was the leading competitor for the global PDA device market. The company offers the Amplatzer™ product line across the globe. The company is expected to maintain its majority share for the foreseeable future.
- PFM Medical was the second-leading competitor in the PDA market in 2025. The company offers the Nit-Occlud® PDA occlusion system, which is available in a range of coil diameters and lengths. Holding a minor portion of the market, the company is expected to see small growth in its global presence.
Patent Ductus Arteriosus Closure Device Market Segmentation Summary
- Patent Ductus Arteriosus Closure Device Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
